CIK 0001022079 · Large accelerated filer
QUEST DIAGNOSTICS INC
Sign in to watch- Ticker
- DGX
- Exchange
- NYSE
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 161387862
- Phone
- 9735202700
- Business address
- 500 PLAZA DRIVE, SECAUCUS, NJ, 07094
- Former names
- CORNING CLINICAL LABORATORIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $16,730,307
- in 5 filings, $16.7M under 10b5-1 plans
Net −$16,730,307. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- PREVOZNIK MICHAEL E −$5.5M SVP & General Counsel sold 38% of stake
- Doherty Catherine T. −$5.5M Executive Vice President sold 24% of stake
- Plewman Patrick −$3.0M SVP for Diagnostic Services sold 44% of stake
- Davis J. E. −$2.4M CEO and President sold 8% of stake
- PFEIFFER GARY M −$292K Director sold 4% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-12 | PREVOZNIK MICHAEL E SVP & General Counsel | Grant or award | +2,345 | 40,823 | ||
| 2025-02-12 | PREVOZNIK MICHAEL E SVP & General Counsel | Grant or award · Non-Qualifed Stock Option (right to buy) | +8,991 | 8,991 | ||
| 2025-02-12 | Plewman Patrick SVP for Diagnostic Services | Grant or award | +2,042 | 18,402 | ||
| 2025-02-12 | Plewman Patrick SVP for Diagnostic Services | Grant or award · Non-Qualifed Stock Option (right to buy) | +7,833 | 7,833 | ||
| 2025-02-12 | KUPPUSAMY KARTHIK SVP, Clinical Solutions | Grant or award | +2,269 | 12,066 | ||
| 2025-02-12 | KUPPUSAMY KARTHIK SVP, Clinical Solutions | Grant or award · Non-Qualifed Stock Option (right to buy) | +8,702 | 8,702 | ||
| 2025-02-12 | Doherty Catherine T. EVP, Regional Businesses | Grant or award | +3,479 | 71,891 | ||
| 2025-02-12 | Doherty Catherine T. EVP, Regional Businesses | Grant or award · Non-Qualifed Stock Option (right to buy) | +13,344 | 13,344 | ||
| 2025-02-12 | DELANEY MARK E SVP & Chief Commercial Officer | Grant or award | +1,815 | 6,439 | ||
| 2025-02-12 | DELANEY MARK E SVP & Chief Commercial Officer | Grant or award · Non-Qualifed Stock Option (right to buy) | +6,960 | 6,960 | ||
| 2025-02-12 | DEPPE MICHAEL J SVP, Corp. Controller & CAO | Grant or award | +454 | 35,399 | ||
| 2025-02-12 | DEPPE MICHAEL J SVP, Corp. Controller & CAO | Grant or award · Non-Qualifed Stock Option (right to buy) | +1,738 | 1,738 | ||
| 2025-02-05 | Gregg Vicky B Director | Sale | −1,250 | $164.57 | $206K | 16,867 |
| 2025-02-05 | DELANEY MARK E SVP & Chief Commercial Officer | Sale | −403 | $164.30 | $66K | 4,624 |
| 2025-01-29 | Gregg Vicky B Director | Other acquisition | +72 | $158.04 | $11K | 18,117 |
| 2025-01-29 | SAMAD SAM Executive Vice President & CFO | Other acquisition | +35 | $158.04 | $6K | 17,539 |
| 2025-01-29 | Plewman Patrick SVP for Diagnostic Services | Other acquisition | +57 | $158.04 | $9K | 16,345 |
| 2025-01-29 | KUPPUSAMY KARTHIK SVP, Clinical Solutions | Other acquisition | +12 | $158.03 | $2K | 9,780 |
| 2025-01-29 | DELANEY MARK E SVP & Chief Commercial Officer | Other acquisition | +4 | $158.03 | $632 | 5,027 |
| 2025-01-02 | RING TIMOTHY M Director | Grant or award · Phantom Stock Units | +281 | 16,081.41 |
Page 16 of 21 · 409 trades